Literature DB >> 4136679

Editorial: Sulphasalazine-induced lung disease.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4136679

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Antibacterial drugs today. I.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Pulmonary vasculitis and ulcerative colitis.

Authors:  J A Forrest; D J Shearman
Journal:  Am J Dig Dis       Date:  1975-05

3.  Salicylazosulfapyridine in inflammatory bowel disease.

Authors:  K M Das; I Sternlieb
Journal:  Am J Dig Dis       Date:  1975-10

Review 4.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

5.  Sulfasalazine-induced pulmonary disease.

Authors:  R H Moseley; K W Barwick; K Dobuler; V A DeLuca
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.